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THE USE OF DIFFERENT CONCENTRATIONS OF LEISHMANIAL ANTIGEN 
IN SKIN TESTING TO EVALUATE DELAYED HYPERSENSITIVITY IN 
AMERICAN CUTANEOUS LEISHMANIASIS
César A. Cuba C u ba1, Philip D. M arsden1, Air C. Barretto1,
Thom as C. Jones2 and Frank R ichards2
Three concentrations o f  Leishmania mexicana amazonensis sonicated whole 
promastigote antigen (30, 9.6 and 3 ug N  in 0.1 ml) wereprepared and 0.1 ml o f each 
inoculated intradermally in topatients who live in one endemic leishmaniasis region in 
Brazil. Patients were divided into groups with active cutaneous leishmaniasis (ACL), 
healed cutaneous leishmaniasis (HCL), mucosal leishmaniasis (M L), and Controls (C).
Skin  reactions were recorded by measuring induration 48 hours after inoculation.
Skin  tests using 9.6 u g N /0 .1 m lyielded thebestd iagnosticresu ltssince97% of30  
patients with active lesions (cutaneous or mucosal) and  83%  with H C L  showed 
reactions o f  5 mm orgreater as compared with 4%  Controls. Tests using 30ug N/O. 1 m l 
causedan unacceptable levei o fsk in  reactions with necrosis (10%  o fA C L patien ts tested 
and 17%  o f  H C L, respectively). Tests using 3 ug N/O. 1 m l were less sensitive since only 
87%  o f  patients with active lesions and 68%  with H C L  had reactions o f5 m m  orgreater.
The 3 ug N/O. 1 m l dose was utilized to ask the questions whether skin delayed 
hypersensitivity decreased with time after the initial lesion and whether mucosal 
involvement is associated with enhaced hypersensitivity to leishmanial antigen.
Decreased delayed hypersensitivity was noted only in thosepatients who had an initial 
lesion more than 30 years ago. The mean induration o f  the reaction in 10 patients with 
M L  was 11.3 mm  ±  7.15, in 41 patients with H C L, 9 .27 mm  ±  6.78 and in 2 0 patients 
with A C L  10. 7 mm  ±  6.10 mm. The percent o f  patients with 5 mm orgreater induration was 
M L  80%, H C L  71%, A C L  90%. Thus, we could not confirm an association between 
enhanced delayed hypersensitivity and mucosal involvement in leishmaniasis.
Key Words: Skin test comparison. Antigen concentrations. Clinicai forms.
American mucocutaneous leishmaniasis.
A  delayed hypersensitivity cutaneous reaction 
to leishmanin is present in most forms of cutaneous and 
mucocutaneous leishmaniasis with the exception of 
diffuse cutaneous leishmaniasis and some cases of post 
kala-azar dermal leishmaniasis^. The skin test was 
first proposed by W agener in 192328, and was 
introduced as a diagnostic aid in American cutaneous 
leishmaniasis in man by Montenegro in 1926*8. it js 
the most widely used skin test in parasitic disease and 
is a valuable ancillary investigation especially in 
mucosal disease where parasites are often difficult to 
find.
Shaw and Lainson 197527 observed that 
patients with mucosal leishmaniasis tended to have 
larger delayed hypersensitivity reactions than those 
with only cutaneous lesions. This suggested that
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mucosal disease could be associated with enhaced 
hypersensitivity response to leishmanial antigens.
This study was designed to compare a) three 
concentrations of antigen in three forms of American 
cutaneous leishmaniasis and b) to examine the 
hypothesis that mucosal disease is associated with 
more marked cutaneous hypersensitivity than 
cutaneous lesions.
M A TERIALS A N D  M ETH OD S
1) Patient population -  Ninety-nine patients 
were studied living in the area of Três Braços, Bahia, 
Brazil, were mucocutaneous leishmaniasis is 
endemic^.
The following groups were established:
a) 20 patients with active cutaneous leishmaniasis 
(ACL) presenting as a skin ulcer.
b) 10 patients with mucosal lesions (ML) of the nose 
or oropharynx as well as a skin scar or active ulcer.
c) 41 patients with the old scars of cutaneous 
leishmaniasis (HCL) which are very typical in 
appearance (Figure 2)
d) 28 patients living in the same area without signs or 
a history of leishmaniasis.
e) 10 volunteers at the University of Brasília cons-
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titued a control group without any history of 
leishmaniasis and living in a nonendemic area.
Of the thirty patients with active cutaneous or 
mucosal lesions 23 (76.6% ) had positive indirect 
fluorescent antibody titers (promastigote antigen) and 
in 20 patients, parasites were isolated from the lesions
(Table 1). Eight stocks from these patients were iden- 
tified as Leishm ania braziliensis braziliensis by 
isoenzyme analysis7.
2) Antigens -  A  stock Leishm ania mexicana 
amazonensis (Josefa) isolated from a patient in 
Brasília was used to prepare the antigens for skin 
testing. This organism was maintained by serial 
passage in hamsters. It gave a rich growth of promas-
tigotes in LIT medium (Liver Infusion Tryptose) and 
was harvested for these studies after eight days.
The organisms were washed twice in phosphate 
buffered saline (pH 7.2), centrifuged, resuspended in 
distilled water and sonicated (five periods of one 
minute each at 20 kh at 4o C). Specimens of the mixed 
suspension were used to determine total nitrogen 
concentration by the micro-Kjeldahl m ethod'0. The 
solution was adjusted to three concentrations of an­
tigen namely 300]_lg Nitrogen per ml, 96 yg N /m l and 
30 ug N /m l using 0.5%  phenol in saline. These 
antigens were kept at -  20° C until use. The antigens 
were tested to confirm their activity in hospitalised 
patients with known leishmanin skin reactions before 
use in this field trial.
Table 1 -  Clinicai and parasitological Jindings in 30 active cases o f  Leishm aniasis (cutaneous and mucosal 
diseases) submitted to skin test.
Patient n.° Clinicai Form Time o f  
Evolution
N.° o f  Lesions Age Serology
(IFAT)
Parasites Identification 
( I  =  Isoenzymes)
1 C* 2m *** 2 55 1:40 + L.b.b. (I)
2 C 12y/ 1 40 - +
3 C 5m 1 42 1:80 -
4 C 2,5m 60 1:40 + L.b.b. (I)
5 C 8m 1 16 - + L.b.b. (I)
6 C lm 1 19 1:40 + L.b.b. (I)
7 C 2m 1 15 1:160 -
8 C 3m 8 1:160 +
9 C 4m 1 18 1:160 + L.b.b. (I)
10 C 5m 4 1:80 +
11 C 6m 1 3 - -
12 c 1.5m 1 18 1:40 +
13 c 2m 1 53 1:40 + L.b.b. (I)
14 c 1.5m 1 45 1:40 +
15 c 3m 1 50 1:80 +
16 c 5m 1 48 1:40 + L.b.b. (I)
17 c ly 66 1:40 +
18 c 2.5m 1 65 1:20 -
19 c 2m 1 28 - +
20 c 3m 1 30 - +
21 M ** 2y 1 35 1:40 -
22 M 3y 59 1:20 -
23 M 3y 1 23 1:80 -
24 M 5.5y 1 35 1:40 -
25 M 4y 1 49 1:640 +
26 M 1.5y 1 10 - N .D
27 M 2y 1 24 1:160 + L.b.b. (I)
28 M 9y 1 37 1:2560 +
29 M 2y 1 9 1:160 N .D
30 M 2y 1 34 - +
* C: Cutaneous disease 
** M: Mucosal disease 
*** m: months
y: years
L.b.b.: Leishmania braziliensis braziliensis 
N.D.: Not Done
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3) The cutaneous te s t-  The antigen suspensions 
were always mixed thoroughly before use. Each 
concentration was inoculated intradermally into the 
ventral surface of the forearm in a dose o f 0.1 ml (Fig. 
1). A control solution of the same volume of 0.5% 
phenol in saline was also inoculated at the same time. 
A t 48 hours the size of induration at each inoculation 
site was measured with a millimeter calliper. An 
induration of 5 or more millimeters was regarded as a 
positive reaction but detailed measurements were 
taken. Figure 2 shows patients with the typical 
mucosal lesion and a cutaneous scar. The results of 
skin testing were analysed calculating the mean 
induration in millimeters and standard deviation for 
each group.
Figure 1. Results o f  delayed hypersensitivity skin testing 
using three doses o f  antigen and  control read a t 48 
hours. The graded dose response is seen.
RESULTS
Table 2 shows the results of the skin test using 
the three antigen concentrations in patients with active 
cutaneous lesions (ACL) and mucosal lesions (ML), 
scars, and Controls from the endemic area. The 
frequency of positive reactions in the Controls from the
Figure2. A  7yearo ldboyw ith  to talabsenceofnasalseptum  
from  mucosal leishmanisasis and a 13 year old 
girl with positive graded skin tests on the left 
forearm  and a characteristic scar on the right 
forearm. Such scars resemble burns being 
slightlv depressed, hypopigmented and fibrotic.
endemic region is very low and present only at high 
antigen concentrations (4%  using a dose of 9.6pgN). 
In patients with active disease or a scar, skin reactivity 
increased with the antigen concentration. There was 
no difference between these two groups in the number 
of positive skin reactions at the highest concentration. 
The highest concentration (3 0 y g /0 .1 ml) however was 
unaceptable since it occasionally caused necrosis at
Table 2 -D e la y ed  hypersensitivity responses to three concentrations o f  leismanin in three patient groups:
Num ber o f  Patients with Reaction o f  >  5mm Using 
Patient Groups Num ber o f  Patients Studied the Concentrations o f  Antigen (  fJg N/O. 1 ml) Given
Be low.
3 9.6 30
a -  b Active Lesions 30 26 (87%) 29 (97%) 30 *(100% )
(ACL and ML)
c Scars 41 27 (68% ) 34 (83%) 40 **(98% )
d Control 28 0 1 (4%) 2 (7%)
* 3(10%) and ** 7(17% ) of patients with necrotic cutaneous reaction
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the inoculation site and axillary lymphadenopathy 
(10% and 17% of patients with active or healed 
disease, respectively). 9.6yg/0.1 ml was the most 
satisfactory dose for routine diagnostic work since it 
was very sensitive but induced a degree of skin reaction 
which was only of temporary inconvenience. The 10 
volunteers from the University of Brasília were nega- 
tive to ali three antigen concentrations.
Reaction size in relation to antigen dose is 
expressed diagramatically in F igure 3 for patients with 
active lesions. This clearly shows the marked 
difference that concentration of antigen makes in skin 
test reactivity in this disease. 3 Ug/0.1 ml yielded a 
scatter of skin reaction in patients with active disease, 
whereas 30 Ug always yielded reaction greater than 
10 mm. In Table 3, the three antigen concentrations 
are related to lesions duration in eight recently 
acquired cases of L.b.brazilensis  infections. Positive 
reactions to ali three antigens were obtained in one 
month after onset of the active lesions. The mean skin 
test reactivity to 3 lJg compared to time after initial 
lesion was 10 mm for less than 5 years, 9 mm for 6 to 
10 years, 14 mm for 11 to  20 years in both groups with 
healed scars and mucosal disease. The intensity of the 
skin test could not be related to the age of the scar in the 
inactive group except that three patients with scars 
more than 30 years in the past yielded reactions to 
3 UgN of 5,4 and 0 mm induration consistent with a 
slight age related decrease in Montenegro skin test 
reactivity.
Table 3 -  Results o f  the three doses o f  skin test antigen in eight patients with proven active L. braziliensis 
braziliensis infection o f  less than 5 months in duration.
Paiient Number Duration o f  
Disease (months)
M agnitude o f  the Reaction in M illimeters *
3Ug N/0.1 ml 9.6 i-ig N /0.1 ml 30 yg N/0.1 ml
1 1 7.5 11.6 15.9
2 2 5.0 13.2 14.2
3 2 5.5 8.0 13.0
4 2.5 13.1 18.7 21.0
5 2 7.0 12.0 19.0
6 3 20.5 18.3 21.7
7 4 15.0 14.0 23.8
8 5 7.5 10.8 10.0
(*) Mean induration size for the three groups are 10, 13.3 and 17.3 mm respectively. Standard deviation. 
(Sx) 5.50; 3.66; 4.80.
Table 4 - S k in  testing in the various form s o f  Leishmaniasis. M ean diameter o f  induration using the 3 Ug N /0.1 ml
Clinicai form  o f  
Leishmaniasis
Num ber o f  Patients Studied M ean Induration in M illimeters ±  1 SD
Active cutaneous 20 10.7 ±  6 .10*
Mucosal 10 11.3 ±  7 .15*
Scar 41 9.3 ±  6.78
(*) Not significant (p <  0.05) compared to scars only
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Figure 3. Comparison o f  the magnitude o f  the skin  test 
reaction to three concentrations o f  leishm anial 
antigen in 30  patients with active lesions.
The dose of 3 U gN /0.1 ml was selected to 
examine the relationship between mucosal disease and 
degree of skin reactivity. Table 4 lists the induration
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diameter in three groups of patients. No significant 
difference between mucosal and cutaneous lesions in 
size of the delayed hypersensitivity reaction was 
noted. By comparing the percent of patients with 
reactions at 5 mm or greater, no differences were 
detected (M L 80% , H C L  71% , A CL 90%).
D ISC U SSIO N
Our study confirms that the Montenegro skin test 
is a useful indicator of active or previous cutaneous 
leishmaniasis, but that the dose of antigen used 
determines the sensitivity of the test. 9.6 UgN per dose 
was found to be the minimum concentration which 
identified most patients. W e confirmed that the skin 
test was always positive by one month after onset of an 
active lesion, and persisted with the same degree of 
reactivity for at least 20 years. Thereafter, a slight 
decrease in skin test reactivity was noted. We found no 
correlation between the occurrence of mucosal disease 
due to leishmaniasis and enhanced skin test reactivity.
Skin testing with leishmania antigen to document 
the prevalence of cutaneous leishmaniasis has been 
used for many years. It has been considered a test with 
good s p e c i f i c i t y 19 an observation confirmed in our 
Brazilian control group, but few careful studies have 
been d o n e *  3. Furtado* has summarised whatis known 
in Brazil regarding cross reactions with other 
diseases. Patients with leprosy and previous visceral 
leishmaniasis may react to leishmanin. Both these 
infections are very rare in our study area.
W hen tests have been done in regions endemic 
for cutaneous leishmaniasis wide variations in skin test 
reactivity in patients without a history of disease or a 
scar have been reported. In our area we have found, in 
other studies^, that 6%  of such patients yield a positive 
test. In the state of São Paulo 25.6%  of people with 
positive skin reactions had no visible sign of 
leishmaniasis^^ ín Minas Gerais 13.4% 12 jn the 
Xingu National Park for Indians in M ato Grosso 
62 .5% ^ in Amazônia 32.9% 8 and in Rio de Janeiro 
state figures vary from 3.7 -  24%  depending on the 
community studied1 7 26 While different conditions of 
the test may account for some of this variation it is 
likely that subclinical infections occur without leaving 
a recongnisable scar.
Increased sensitivity of the test by use of high 
antigen concentration was first reported by R o tb e r g ^ 4  
who showed that with a concentration of 1 x 107 
promastigotes per milliliter 92% of patients with 
cutaneous leishmaniasis had positive reactions. Melo 
et a l,(\  utilizing a concentration of 40 )Jg of protein 
nitrogen per milliliter had a 96%  positivity rate and 
suggested that an antigen of this strenght was desirable. 
Our results support their findings but high strength 
antigens do produce undesirable skin reaction. On the 
other hand, we found that when the weakest antigen 
concentration was used 32%  of the 41 patients with 
scars were non reactors. This is important since 
leishmanin skin test surveys are frequently used to
assess the incidence and prevalence of cutaneous 
leishmaniasis using similar antigen concentrations.
Our studies also confirm that antigens prepared 
from a different organism, L. m. amazonensis, induce 
satisfactory skin reactions in patients with proven 
lesions due to L. braziliensis braziliensis. This is not 
surprising since heterologous antigens outside the 
leishmania genus, such as T. c ru z fl1 22 ancj L epto- 
monas pessoafl yield positive reactions in cutaneous 
leishmaniasis.
The time of onset of skin test reactivity and its 
duration after the initial lesion has beenof interest. We 
have noted, as have others^ 21_ that the test may be 
negative early in infection but, by one month, nearly ali 
are positive.
Recently three groups of workers have studied 
leishmanin reactivity some years after an initial test 
and reported a decline in incidence of positive 
reactors14 15 20. This is a variance with the view that, 
once established, skin hypersensitivity persists inde- 
finitely. Analysis of our data does not suggest that the 
time elapsed between the healing and the skin testing 
influences the intensity of the reaction except when 
lesions have been healed for more than 2 0  y e a r s *9.
The destructive effects of espundia have been 
attributed to a hypersensitivity phenomenorP or 
autoimmune reaction11. It has been suggested that the 
basic mechanisms of cutaneous and mucosal disease 
depend on the toxicity and immunogenicity of the 
parasites25. To test the hypothesis that mucosal 
disease is associated with a greater degree of skin 
hypersensitivity to leishmanin it was necessary to 
select the results using the lowest concentration of 
antigen in view of our data in Table 2. We detected no 
significant difference in skin test reactivity between 
mucosal and active cutaneous cases or mucosal and 
healed cutaneous cases. This is at variance with the 
observations made by Shaw and Lainson 197527, in a 
different region of Brazil.
Our data confirm the necessity to standardise 
the procedure of the Montenegro both in the antigen 
used and the methodology of the test reading. Ideally, 
one carefully standardized antigen should be distri- 
buted by an international agency. This standardization 
should include careful taxonomy of the strain used for 
antigen production, concentration of promastigotes 
per milliliter, preparation method for preserving the 
antigens and total nitrogen determination. Each lot is 
best standardized biologically in infected man against 
a stock of antigen of known activity. An exoantigen has 
been reported to yield an immediate hypersensitivity 
reaction in 74.4%  of 41 patients27. This observation is 
of practical importance and should be further inves- 
tigated since return after two days to read the reaction 
is often difficult under field conditions.
A D D E N D U M
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Immunology and Immunopathology 27: 176-186, 
1983), have shown that the skin test response 
(as mean induration in mm.) was significantly greater 
in mucocutaneous leishmaniasis (M CL, 11 patients) 
than in 32 patients with localized cutaneous 
leishmaniasis (LCL).
This difference from our results might be ex- 
plained by the small groups examined in both series 
and the fact that some of our patients with mucosal 
disease had secondary malnutrition which would 
depress skin responses.
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